Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Richard M Schwartz

A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation Development.

scientific article published on 29 June 2016

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

scientific article

A proof of concept for structure-based vaccine design targeting RSV in humans

scientific article published on 01 August 2019

A serum-free Vero production platform for a chimeric virus vaccine candidate

scientific article

An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial

scientific article published in June 2017

CHO-DHFR cell line development platform: Application of Clonepix and Automated Mini Bioreactor (AMBR) technologies to meet accelerated timelines

scientific article

Characterization of N-glycosylation profiles from mammalian and insect cell derived chikungunya VLP.

scientific article published on 21 April 2016

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

scientific article

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination.

scientific article published on 31 May 2012

Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.

scientific article published on 27 February 2009

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

scientific article published on 7 May 2015

Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination ⬇️

scientific article published on April 4, 2012

Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity

scientific article published on 06 May 2009

Development and application of a reversed-phase high-performance liquid chromatographic method for quantitation and characterization of a Chikungunya virus-like particle vaccine

scientific article

Development of a High Yielding Bioprocess for a Pre-fusion RSV Subunit Vaccine

scientific article published on 14 October 2020

Development of a mammalian cell culture process for rapid Clinical-Scale production of novel Influenza Nanoparticle vaccines.

scientific article

Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions

scientific article

Development of high-throughput and high sensitivity capillary gel electrophoresis platform method for Western, Eastern, and Venezuelan equine encephalitis (WEVEE) virus like particles (VLPs) purity determination and characterization.

scientific article

Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical Trial

scientific article published on 01 April 2020

Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design

scientific article

Phase 1 study of pandemic H1 DNA vaccine in healthy adults

scientific article

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

scientific article published on 20 January 2004

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

scientific article published on 28 August 2019

Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.

scientific article published on 24 January 2018

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

scientific article published on 14 August 2014

Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults

scientific article published on September 2015

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

scientific article published on 4 December 2017

Structural Characterization and Formulation Development of a Trivalent Equine Encephalitis Virus-Like Particle Vaccine Candidate

article

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

scientific article published on December 2015

Paulina is supported by:

About Paulina

Help